A study for safety and efficacy of VELGRAFT containing Human Bone marrow derived Mesenchymal Stem Cell and Mesenchymal stem cell differentiated adipocytes as a skin substitute on wounds of Diabetic Foot Ulcers
Implementing Organization
Project Overview
Velgraft is a biocompatible and biodegradable skin substitute, and all the constituents of Velgraft has been in medical use for many years and their trouble free records serves to underline the safety of this product. Mesenchymal stem cell has been used widely used for the treatment of many diseases and they have been proved to be non-immunogenic and non-tumorigenic. Additionally, cells contained in Velgraft are cultured in xenogeneic free medium, reducing risk of sensitivity to animal products.
The flexible and porous matrix of Velgraft is comprised of natural polymers which help in reducing the healing time.
Devices and Diagnostics, Wound healing implant, Biopharma
Status
Pre-commercilization stage (Phase-I clinical trials are completed and CDSCO application is under process, Phase-II trials will be initiated after CDSCO approval)
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Acces sibility Controls